Annexon, Inc.
ANNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001528115
In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Annexon, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +16 vs. Q4 2022
- Shares held
- 53.8M
- +5.48M (+11.3%) vs. Q4 2022
- Total value
- $207.6M
- −$35.7M (−14.7%) vs. Q4 2022
- New holders
- 32
- 30 more added
- Sold out
- 16
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $1.02B |
| Q1 2026 | 217 | $863.7M |
| Q4 2025 | 168 | $687.2M |
| Q3 2025 | 144 | $309.2M |
| Q2 2025 | 129 | $238.7M |
| Q1 2025 | 148 | $192.1M |
| Q4 2024 | 153 | $574.6M |
| Q3 2024 | 142 | $651.8M |
| Q2 2024 | 140 | $526.9M |
| Q1 2024 | 127 | $679.4M |
| Q4 2023 | 99 | $365.7M |
| Q3 2023 | 93 | $126.0M |
| Q2 2023 | 95 | $190.0M |
| Q1 2023 | 100 | $207.6M |
| Q4 2022 | 84 | $243.3M |
| Q3 2022 | 72 | $292.3M |
| Q2 2022 | 78 | $144.9M |
| Q1 2022 | 100 | $105.9M |
| Q4 2021 | 97 | $445.7M |
| Q3 2021 | 82 | $708.6M |
| Q2 2021 | 74 | $873.7M |
| Q1 2021 | 72 | $1.04B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Annexon, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 0 | $0 | 0.00% | −3,780,694−100.0% | Sold out |
| Fairmount Funds Management LLC | 0 | $0 | 0.00% | −3,358,563−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −302,734−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −164,558−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −161,360−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −145,564−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −65,380−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −50,263−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −26,800−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −21,605−100.0% | Sold out |
| EWG Elevate Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −11,836−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −8,301−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| Freedom Wealth Alliance, LLC | 0 | $0 | 0.00% | −3,889−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −405−100.0% | Sold out |